<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="uk">
		<id>http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Ideal_Way_To_Prevent_Sitaxentan_Disappointments</id>
		<title>Ideal Way To Prevent Sitaxentan Disappointments - Історія редагувань</title>
		<link rel="self" type="application/atom+xml" href="http://istoriya.soippo.edu.ua/index.php?action=history&amp;feed=atom&amp;title=Ideal_Way_To_Prevent_Sitaxentan_Disappointments"/>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Ideal_Way_To_Prevent_Sitaxentan_Disappointments&amp;action=history"/>
		<updated>2026-05-05T16:45:26Z</updated>
		<subtitle>Історія редагувань цієї сторінки в вікі</subtitle>
		<generator>MediaWiki 1.24.1</generator>

	<entry>
		<id>http://istoriya.soippo.edu.ua/index.php?title=Ideal_Way_To_Prevent_Sitaxentan_Disappointments&amp;diff=158782&amp;oldid=prev</id>
		<title>Leek58pond: Створена сторінка: Thus, a total of 26 case�Ccontrol studies[10-16, 29, 31-48] met inclusion criteria and were included in the current meta-analysis (Fig.?1). Characteristics an...</title>
		<link rel="alternate" type="text/html" href="http://istoriya.soippo.edu.ua/index.php?title=Ideal_Way_To_Prevent_Sitaxentan_Disappointments&amp;diff=158782&amp;oldid=prev"/>
				<updated>2017-03-30T07:36:02Z</updated>
		
		<summary type="html">&lt;p&gt;Створена сторінка: Thus, a total of 26 case�Ccontrol studies[10-16, 29, 31-48] met inclusion criteria and were included in the current meta-analysis (Fig.?1). Characteristics an...&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Нова сторінка&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Thus, a total of 26 case�Ccontrol studies[10-16, 29, 31-48] met inclusion criteria and were included in the current meta-analysis (Fig.?1). Characteristics and genotype distribution of each case�Ccontrol study are shown in Table?1. Figures?2-5 show the summary of meta-analysis for GSTM1and GSTT1 polymorphisms with asthma risk. When all groups were pooled, the random-effects model was conducted if the heterogeneity was significant; otherwise [http://www.selleckchem.com/products/BIBW2992.html Afatinib supplier] the fixed-effects model was conducted. Twenty-six studies with a total of 3680 cases and 4350 controls were included in the GSTM1 polymorphism meta-analysis. For the GSTT1 polymorphism, 22 studies with a total of 3167 cases and 3209 controls were included. The pooled results showed a significant association for both the GSTM1 polymorphism (null vs present, OR?=?1.452; 95% CI: 1.192�C1.770; P?[http://www.selleckchem.com/products/CAL-101.html click here] vs present, OR?=?1.792; 95% CI: 1.293�C2.483; P?[https://en.wikipedia.org/wiki/Sitaxentan Sitaxentan] 95% CI: 1.018�C1.667; P?=?0.036; I2?=?36.1%), Africa (OR?=?2.175; 95% CI: 1.560�C3.031; P?&lt;/div&gt;</summary>
		<author><name>Leek58pond</name></author>	</entry>

	</feed>